POTASSIUM TRIFLUORO[(4-FLUOROPHENYL)METHYL]BORANUIDE, 95%, 5g

Succinamide, 98.0%, 5g

3,4,7,8-Tetramethyl-1,10-phenanthroline, 95.0%, 10g

2,4-Difluoro-3-methylbenzoic acid, 95.0%, 1g

6-AMINO-1H-INDAZOLE-7-CARBOXYLIC ACID, 95%, 10g

10-Acetyl-1,1,7,7-tetramethyl-2,3,6,7-tetrahydro-1H-pyrano[2,3-f]pyrido[3,2,1-ij]quinolin-11(5H)-one, 98%, 200mg

Phase contrast slide set with 10x and S40x PLPHi IOS infinity corrected objectives and phase contrast rings for 10x/S40x

4-Chlorophenyl Chloroformate>98.0%(GC)(T)5g

6-BROMO-5-CHLORO-3,4-DIHYDRO-2H-BENZO[B][1,4]OXAZINE, 95.0%, 500mg

(4-Chlorophenyl)(phenyl)methanol, 95.0%, 500g

2,6-Dichloro-isonicotinic acid ethyl ester, 95.0%, 25g

1-Methyl-3-(trifluoromethyl)-1H-pyrazole-4-carboxamide, 95.0%, 100mg

Tert-butyl(1s,2r,5r)-2-(aminomethyl)-3-azabicyclo[3.1.0]hexane-3-carboxylate, 98%, 250mg